Clinical Trials

The Clinical Trials at CNCI Kolkata are an integral part of the institute’s commitment to advancing cancer treatment and research. These trials are designed to evaluate new therapies, treatment protocols, and diagnostic techniques, contributing to the scientific understanding of cancer and improving patient outcomes.
Key aspects of CNCI Kolkata's Clinical Trials include:
Phase I to IV Trials: CNCI conducts a range of clinical trials, including early-phase trials (Phase I) to test new treatments and later-phase trials (Phase II-IV) that assess efficacy, safety, and long-term effects of treatments.
Collaboration with Research Institutions: The institute collaborates with national and international research organizations, pharmaceutical companies, and academic institutions to bring cutting-edge therapies to patients.
Focus Areas: The clinical trials primarily focus on oncology, including innovative therapies such as targeted therapies, immunotherapies, and personalized cancer treatment approaches, across various types of cancer.
Ethical Oversight: All clinical trials at CNCI Kolkata are conducted following strict ethical guidelines and regulatory approvals to ensure patient safety and well-being. Institutional Review Boards (IRBs) and Ethics Committees oversee the trials to ensure compliance with national and international standards.
Patient Participation: CNCI encourages patients to participate in clinical trials as part of their treatment options, offering access to the latest therapies and contributing to the advancement of cancer treatment research.
Clinical Research Infrastructure: CNCI has state-of-the-art facilities and dedicated clinical research teams that ensure the smooth execution of clinical trials, from patient recruitment to data collection and analysis.
Through its clinical trials, CNCI Kolkata aims to lead in the field of cancer research, offering patients access to innovative treatments and contributing to the global fight against cancer